7 rezultatus
FIELD OF THE INVENTION
The present invention relates to a novel compound and pharmaceutical composition thereof for treating mammalian cell proliferative disorders, chemo-therapy resistance and virus infections, particularly a novel .gamma.-butyrolactone compound and pharmaceutical composition
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to sigma(a) receptors ligands with anti-apoptotic and/or pro-apoptotic properties for use in connection with exhibiting prototypical cytoprotective properties associated with cytoregenerative activity developed by
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a novel method for synthesizing an .alpha.-methylene-.gamma.-butyrolactone which is one of basic structures often shown in drugs such as an anti-cancer agent. More particularly, the present invention relates to a
TECHNICAL FIELD OF THE INVENTION
The present invention relates to the therapeutical application of .alpha.-methylene-.gamma.-butyrolactone derivatives.
BACKGROUND OF THE INVENTION
.alpha.-methylene-.gamma.-butyrolactone constitute an important group of natural products which possess wide-ranging
FIELD OF THE INVENTION
The present inventions are generally in the fields of pharmaceutically active lactones, their pharmaceutical formulations, and methods of use for treating pain.
BACKGROUND OF THE INVENTION
Despite the development of many different compounds which are useful in the treatment of
FIELD OF THE INVENTION
The present inventions are generally in the fields of pharmaceutically active lactones, their pharmaceutical formulations, and methods of use for treating pain.
BACKGROUND OF THE INVENTION
Despite the development of many different compounds which are useful in the treatment of
This application is a national phase application under 35 U.S.C. .sctn.371 of International Application No. PCT/IN2009/000153 filed 05 Mar. 2009, which claims priority to Indian Application No. 527/DEL/2008 filed 05 Mar. 2008. The entire text of each of the above-referenced disclosures is